Cargando…
Combination of Whole-Body Baseline CT Radiomics and Clinical Parameters to Predict Response and Survival in a Stage-IV Melanoma Cohort Undergoing Immunotherapy
SIMPLE SUMMARY: The use of immunotherapeutic agents significantly improved stage-IV melanoma patients’ overall progression-free survival. To identify patients who do not benefit from immunotherapy, both clinical parameters and experimental biomarkers such as radiomics are currently being evaluated....
Autores principales: | Peisen, Felix, Hänsch, Annika, Hering, Alessa, Brendlin, Andreas S., Afat, Saif, Nikolaou, Konstantin, Gatidis, Sergios, Eigentler, Thomas, Amaral, Teresa, Moltz, Jan H., Othman, Ahmed E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221470/ https://www.ncbi.nlm.nih.gov/pubmed/35740659 http://dx.doi.org/10.3390/cancers14122992 |
Ejemplares similares
-
Can Whole-Body Baseline CT Radiomics Add Information to the Prediction of Best Response, Progression-Free Survival, and Overall Survival of Stage IV Melanoma Patients Receiving First-Line Targeted Therapy: A Retrospective Register Study
por: Peisen, Felix, et al.
Publicado: (2023) -
A Machine learning model trained on dual-energy CT radiomics significantly improves immunotherapy response prediction for patients with stage IV melanoma
por: Brendlin, Andreas Stefan, et al.
Publicado: (2021) -
Diagnostic Performance of a Contrast-Enhanced Ultra-Low-Dose High-Pitch CT Protocol with Reduced Scan Range for Detection of Pulmonary Embolisms
por: Brendlin, Andreas S., et al.
Publicado: (2021) -
AI Lung Segmentation and Perfusion Analysis of Dual-Energy CT Can Help to Distinguish COVID-19 Infiltrates from Visually Similar Immunotherapy-Related Pneumonitis Findings and Can Optimize Radiological Workflows
por: Brendlin, Andreas S., et al.
Publicado: (2021) -
Noninvasive, longitudinal imaging-based analysis of body adipose tissue and water composition in a melanoma mouse model and in immune checkpoint inhibitor-treated metastatic melanoma patients
por: Thaiss, Wolfgang M., et al.
Publicado: (2020)